SAN FRANCISCO – Preparing for infectious disease outbreaks with potentially global impacts, both in the U.S. and abroad, must be a permanent and pivotal focus of the Centers for Disease Control and Prevention, CDC Director Dr. Robert Redfield said here in a conversation with IDSA President Dr. Paul Auwaerter and HIV Medicine Association Chair Dr. Melanie […]
The following is a guest post by Stephanie Mullen, DrPH, and Jim Thomas, PhD of MEASURE Evaluation USAID announced September 26 a new approach to fight tuberculosis: the Global Accelerator to End TB, a business model to treat 40 million people by 2022 through performance-based investments. One of USAID’s initial efforts on this front is […]
HIV
While plan will target 48 “hot spots” with services, and people at high risks with PrEP, will it change policies that fuel HIV? More details are […]
Tuberculosis
With the release of a “pre-final text” of updated guidelines for treatment of multidrug- and rifampicin-resistant tuberculosis, the World Health Organization made official substantial changes to […]
Research & Development
A trial to test the safety of, and immune response prompted by, the latest candidate for a vaccine to protect against Zika virus infection has begun […]
Policy
Drawing on previously published findings and on-the-ground interviews, a report from Planned Parenthood details damage to global health gains, including in closed programs, weakened civil society, […]